ReviewFrontiers in oncology2026
Application of photoacoustic imaging in tumor diagnosis and surgical treatment.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photoacoustic imaging (PAI) is an emerging hybrid modality that combines high-contrast optical imaging with high-resolution ultrasound imaging, offering significant potential for tumor diagnosis and surgical guidance. This review provides a concise and focused overview of the principles, technological advancements, and clinical applications of PAI in oncology. We begin by introducing the basic mechanism of PAI, including the photoacoustic effect and the differentiation between the NIR-I and NIR-II imaging windows. The review then systematically examines the role of PAI in preoperative tumor characterization, intraoperative margin assessment, and vascular involvement detection. Emphasis is placed on how PAI enables label-free, real-time visualization of tumor microenvironments, including hemoglobin distribution, oxygen saturation, and nuclear morphology. Key technological innovations, such as multispectral optoacoustic tomography (MSOT) and optical-resolution photoacoustic microscopy (OR-PAM), are discussed with a focus on their inherent depth-resolution trade-offs. We also highlight recent advances in exogenous contrast agents and their potential for molecular imaging. critically evaluating their stability, toxicity, and translational hurdles. By synthesizing current evidence and directly addressing key technical and clinical limitations-including penetration depth, laser safety, reconstruction artifacts, and lack of standardization-this review provides a comprehensive and critical evaluation of PAI's capabilities, limitations, and future directions in tumor diagnosis and surgical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.